| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18827494 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 102 journal articles in the PubMed database | Email to a friend | | |
| Yamamoto H, Sekine I, Yamada K, et al.
Gender Differences in Treatment Outcomes among Patients with Non-Small Cell Lung Cancer Given a Combination of Carboplatin and Paclitaxel. [JOURNAL ARTICLE]
Oncology 2008 Oct 1; 75(3-4):169-174.
Abstract | Full Citation | Find Related Articles | | Rosell R, Gatzemeier U, Betticher DC, et al.
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
Ann Oncol 2002 Oct; 13(10):1539-49.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Choong NW, Vokes EE, Haraf DJ, et al.
Phase I Study of Induction Chemotherapy and Concomitant Chemoradiotherapy with Irinotecan, Carboplatin, and Paclitaxel for Stage III Non-small Cell Lung Cancer. [JOURNAL ARTICLE]
J Thorac Oncol 2008 Jan; 3(1):59-67.
Abstract | Full Citation | Find Related Articles | | Choy H, Devore RF, Hande KR, et al.
A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study). [Clinical Trial, Clinical Trial, Phase II, Journal Article]
Int J Radiat Oncol Biol Phys 2000 Jul 1; 47(4):931-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Stinchcombe TE, Morris DE, Lee CB, et al.
Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-small cell lung cancer. [Journal Article]
J Thorac Oncol 2008 Mar; 3(3):250-7.
Abstract | Full Citation | Find Related Articles | | Langer CJ, Leighton JC, Comis RL, et al.
Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis. [Clinical Trial, Clinical Trial, Phase II, Journal Article]
J Clin Oncol 1995 Aug; 13(8):1860-70.
Abstract | Full Citation | Find Related Articles | | Hirsh V, Soulieres D, Duclos M, et al.
Phase II Multicenter Trial with Carboplatin and Gemcitabine Induction Chemotherapy Followed by Radiotherapy Concomitantly with Low-Dose Paclitaxel and Gemcitabine for Stage IIIA and IIIB Non-small Cell Lung Cancer. [JOURNAL ARTICLE]
J Thorac Oncol 2007 Oct; 2(10):927-932.
Abstract | Full Citation | | Strauss GM, Lynch TJ, Elias AD, et al.
Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis. [Clinical Trial, Clinical Trial, Phase I, Journal Article]
Semin Oncol 1997 Aug; 24(4 Suppl 12):S12-73-S12-80.
Abstract | Full Citation | Find Related Articles | | Socinski MA, Schell MJ, Bakri K, et al.
Second-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study]
Cancer 2002 Sep 15; 95(6):1265-73.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
